Veterinary APIs: Market Size & Forecast 2026

The global veterinary active pharmaceutical ingredients (API) market sits at roughly USD 6.0 billion in 2025 (base year) on a 6.2% seven-year CAGR through 2032, anchored by mature livestock end-use demand (52% livestock / 33% companion animals / 9% aquaculture / 6% other), a concentrated Asian manufacturing base, and an evolving antimicrobial-stewardship regime that is reshaping the product mix more than the headline growth rate [Claight estimate: derived from segment-share-weighted build against the HealthforAnimals global veterinary products trade anchor of ~USD 30B for finished goods, with APIs estimated at ~20% of finished value]. Reference ivermectin-class and ceftiofur-intermediate precursors sit in a USD 36,000-42,000/MT band across the major regions, a band the buyer should verify at the point of contract. > **Analyst Take.** Our view: the right sequence is to lock two-precursor

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.